Literature DB >> 17207602

Isolation and characterization of some potential impurities in ropinirole hydrochloride.

B Sahasrabuddhey1, R Nautiyal, H Acharya, S Khyade, P K Luthra, P B Deshpande.   

Abstract

Three impurities in ropinirole hydrochloride drug substance at levels approximately 0.06-0.15% were detected by reverse-phase high performance liquid chromatography (HPLC). These impurities were isolated from the drug substance. These impurities were analyzed using reverse-phase HPLC. Based on the spectral data (IR, NMR and MS), structures of these impurities were characterized as 4-[2-(propylamino) ethyl]-1,3-dihydro-2H-indol-2-one hydrochloride (impurity-A), 5-[2-(diropylamino) ethyl]-1,4-dihydro-3H-benzoxazin-3-one hydrochloride (impurity-B) and 4-[2-(diropylamino) ethyl]-1H-indol-2,3-dione hydrochloride (impurity-C). Synthesis of these impurities is discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17207602     DOI: 10.1016/j.jpba.2006.11.030

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Box-Behnken supported validation of stability-indicating high performance thin-layer chromatography (HPTLC) method: An application in degradation kinetic profiling of ropinirole.

Authors:  Gulam Mustafa; Alka Ahuja; Sanjula Baboota; Javed Ali
Journal:  Saudi Pharm J       Date:  2011-12-04       Impact factor: 4.330

2.  Use of spectroscopic, zeta potential and molecular dynamic techniques to study the interaction between human holo-transferrin and two antagonist drugs: comparison of binary and ternary systems.

Authors:  Mona Kabiri; Zeinab Amiri-Tehranizadeh; Ali Baratian; Mohammad Reza Saberi; Jamshidkhan Chamani
Journal:  Molecules       Date:  2012-03-12       Impact factor: 4.411

3.  Developing an Improved UHPLC Method for Efficient Determination of European Pharmacopeia Process-Related Impurities in Ropinirole Hydrochloride Using Analytical Quality by Design Principles.

Authors:  Tim Tome; Aleš Obreza; Zdenko Časar
Journal:  Molecules       Date:  2020-06-10       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.